HANKOOK Corporation Inc. (KOSDAQ:A050540) agreed to acquire Genome Biologics Asia Pacific Co., Ltd. from Global Bio Investment Fund for KRW 21.1 billion on December 26, 2018. As per the terms, HANKOOK shall make a deposit of KRW 20 billion on December 27, 2018 and the balance of KRW 1.1 billion on January 4, 2019. HANKOOK shall acquire 0.2 million shares of Genome Biologics representing the entire share capital. Genome Biologics Asia Pacific reported total assets of KRW 79.35 billion. The transaction is expected to be completed on January 4, 2019. Samil PricewaterhouseCoopers acted as external rating institution.